Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xu-Yang Shang
Observed names:
X.Q. Shang,
Xiumin Shang
Institution:
Henan University of Chinese Medicine
Observed institutions:
Henan University of Chinese Medicine,
Shanghai Jiao Tong University,
Shanghai Changning Maternity and Infant Health Hospital,
Henan Cancer Hospital,
State Key Laboratory of Medical Genomics
ORCID:
0000-0001-6234-8780
Observed ORCID:
0000-0001-6234-8780
OpenAlex ID:
A5012553288
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis
2023
·
Hao Wang
, Yinuo Li
, et al.
·
Journal of Gynecologic Oncology
·
20
SCARA5 deficiency inhibits ferroptosis via regulating iron homeostasis and results in sorafenib resistance in hepatocellular carcinoma
2025
·
Cong Chen
, Lan Wang
, et al.
·
Cellular Signalling
·
10
[Pharmacokinetics of four characteristic components from ethanol extract of Rehmanniae Radix in normal and depression model rats].
2026
·
Qian Fei
, Hong-Zhi An
, et al.
·
PubMed
300P Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer
2022
·
X.Q. Shang
, T. Wang
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
4
Citation count:
30
H-index:
2
I10-index:
2
Year
Topic
Type